|
|
Combination Chemotherapy Better Than Erlotinib as Initial Treatment for Advanced NSCLC
|
| Link ID |
4244 |
| Title |
Combination Chemotherapy Better Than Erlotinib as Initial Treatment for Advanced NSCLC |
| Url |
http://www.medscape.com/viewarticle/571926?src=rss |
| Description |
For patients with advanced non-small-cell lung cancer (NSCLC) and a performance status (PS) of 2, combination chemotherapy is superior to erlotinib therapy as initial treatment, according to a report in the February 20th Journal of Clinical Oncology. Reuters Health Information |
| Category |
Articles > Pharmacists |
| Keywords |
|
| Date |
Mar 25, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Pharmacists |
| 1. |
Sirolimus Stents Better at Reducing Restenosis
|
|
|
Sirolimus-eluting stents may offer an advantage over bare-metal stents in patients with ST segment elevation myocardial infarction (STEMI), Dutch researchers report in the February 12th issue of the Journal of the American College of Cardiology. Reuters Health Information
|
| 2. |
Bosentan May Offer Modest Benefits for Idiopathic Pulmonary Fibrosis
|
|
|
Bosentan, a dual endothelin receptor antagonist, may be a useful treatment for idiopathic pulmonary fibrosis, especially biopsy-proven disease, according to a report in the American Journal of Respiratory and Critical Care Medicine for January. Reuters Health Information
|
| 3. |
Cyclophosphamide Improves Scleroderma but Benefits Wane
|
|
|
One year of treatment with cyclophosphamide results in significant improvements in lung function, skin scores, dyspnea, and quality of life in patients with scleroderma lung disease, new findings indicate. While these effects persist for several months after treatment cessation, they are generally no longer apparent after 24 months. Reuters Health Information
|
| 5. |
Physician-Directed Home Care Reduces COPD Exacerbations in Elderly
|
|
|
A system employing hospital levels of care delivered at home to elderly patients with chronic obstructive pulmonary disease (COPD) exacerbations provides results superior to those with inpatient treatment, according to Italian and US researchers. Reuters Health Information
|
|
|
